Dr. Daniel Corsi is a Scientist at CHEO RI and an Epidemiologist with BORN Ontario. He is an Assistant Professor at the University of Ottawa Department of Obstetrics and Gynecology and with the School of Epidemiology and Public Health. Daniel is an epidemiologist with a focus on maternal substance use in pregnancy. His research involves using innovative methods to understand the influence of socioeconomic status and substance use on maternal-child health in the perinatal period and across the life course. He has pursued this research both in the context of Canada as well as globally.
He is the Principal Investigator on a CIHR-funded project looking at long-term development in children prenatally exposed to cannabis. His research track record in this field includes more than 90 original articles and book chapters. Daniel has mentored over 20 scholars from undergraduates, graduates, postdoctoral fellows, and trainees in various capacities. He is currently accepting graduate students through the University of Ottawa.
Maternal cannabis use in pregnancy and child neurodevelopmental outcomes
With the legalization of recreational cannabis in many jurisdictions, there is concern about potentially adverse childhood outcomes related to prenatal exposure.
Association between interpregnancy interval and subsequent stillbirth in 58 low-income and middle-income countries: a retrospective analysis using Demographic and Health Surveys
Although interpregnancy intervals of less than 12 months were associated with increased risk of stillbirth, these effects were attenuated when considering second and third intervals, suggesting the association in the first interval might not be causal.
Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes
Among pregnant women in Ontario, Canada, reported cannabis use was significantly associated with an increased risk of preterm birth.
Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017
Cannabis use in pregnancy has increased since 2012 in Ontario and was reported in about 2% of pregnancies in 2017.